Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The Tie receptor tyrosine kinases and their angiopoietin (Ang) ligands play central roles in developmental and tumor-induced angiogenesis. Here we present the crystal structures of the Tie2 ligand-binding region alone and in complex with Ang2. In contrast to prediction, Tie2 contains not two but three immunoglobulin (Ig) domains, which fold together with the three epidermal growth factor domains into a compact, arrowhead-shaped structure. Ang2 binds at the tip of the arrowhead utilizing a lock-and-key mode of ligand recognition-unique for a receptor kinase-where two complementary surfaces interact with each other with no domain rearrangements and little conformational change in either molecule. Ang2-Tie2 recognition is similar to antibody-protein antigen recognition, including the location of the ligand-binding site within the Ig fold. Analysis of the structures and structure-based mutagenesis provide insight into the mechanism of receptor activation and support the hypothesis that all angiopoietins interact with Tie2 in a structurally similar manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the previously identified TIE2 binding site in ANGPT2 FLD (16) is accessible in our ANGPT2147–496–α5Calf1-2 SAXS model.”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [16]
In the citing paper
“Interestingly, the model of the dimeric ANGPT2147–496 in complex with the inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [16]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715 · cited 1×
“and refinement proceeded with molecular dynamics and energy minimization in CN”
BackgroundJones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“This arises as a result of two distinct processes termed vasculogenesis (formation of major primitive blood vessels) and angiogenesis (remodeling and extension of the adult vasculature”
BackgroundVascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“dtd" [ ]> The development of the adult cardiovascular system involves the differentiation of endothelial cells from precursor angioblasts and their subsequent migration, growth and sproutin”
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227 · cited 1×
“or from ligand-induced conformational changes in the receptor that result in its dimerization (as in EGF”
BackgroundBlood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215 · cited 1×
“dtd" [ ]> The development of the adult cardiovascular system involves the differentiation of endothelial cells from precursor angioblasts and their subsequent migration, growth and sproutin”
Cited by
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Fagiani, E., & Christofori, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.08.018 · Cited by 676
Design of protein-binding proteins from the target structure alone
Cao, L., Coventry, B., Goreshnik, I., Huang, B., Sheffler, W., Park, J. S., Jude, K. M., Marković, I., Kadam, R. U., Verschueren, K. H. G., et al. (2022) · Nature · doi:10.1038/s41586-022-04654-9 · Cited by 577
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Saharinen, P., Eklund, L., Pulkki, K., Bono, P., & Alitalo, K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.015 · Cited by 478
Targeting the ANGPT–TIE2 pathway in malignancy
Huang, H., Bhat, A., Woodnutt, G., & Lappe, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2894 · Cited by 468
Regula, J. T., Lundh von Leithner, P., Foxton, R., Barathi, V. A., Cheung, C. M. G., Bo Tun, S. B., Wey, Y. S., Iwata, D., Dostalek, M., Moelleken, J., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505889 · Cited by 376
“We therefore used the angiopoietin receptor-binding domains (RBDs) as a Fc fusion protein (Barton et al, 2006).”
Spatial regulation of receptor tyrosine kinases in development and cancer
Casaletto, J. B., & McClatchey, A. I. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3277 · Cited by 359
Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity
Souma, T., Tompson, S. W., Thomson, B. R., Siggs, O. M., Kizhatil, K., Yamaguchi, S., Feng, L., Limviphuvadh, V., Whisenhunt, K. N., Maurer-Stroh, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85830 · Cited by 259
“The Ig2 domain, which functions as a ligand-binding domain (37, 38), is also critical for stable protein expression, as loss of this Ig domain in p.”
BackgroundLECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis
Xu, M., Xu, H.-H., Lin, Y., Sun, X., Wang, L.-J., Fang, Z.-P., Su, X.-H., Liang, X.-J., Hu, Y., Liu, Z.-M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.021 · Cited by 223
Angiopoietin–Tie signalling in the cardiovascular and lymphatic systems
Eklund, L., Kangas, J., & Saharinen, P. (2017) · Clinical Science · doi:10.1042/cs20160129 · Cited by 202
Amelioration of sepsis by TIE2 activation–induced vascular protection
Han, S., Lee, S.-J., Kim, K. E., Lee, H. S., Oh, N., Park, I., Ko, E., Oh, S. J., Lee, Y.-S., Kim, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9260 · Cited by 203
“We propose that ABTAA binds to a certain portion within A2D (269 to 496 amino acid residues), which is separate from the TIE2binding portion (53).”
BackgroundTie1-Tie2 Interactions Mediate Functional Differences between Angiopoietin Ligands
Seegar, T. C. M., Eller, B., Tzvetkova-Robev, D., Kolev, M. V., Henderson, S. C., Nikolov, D. B., & Barton, W. A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.007 · Cited by 183
“…studies originally identified both the Ig and EGF domains of Tie2 as necessary and sufficient for angiopoietin binding (Barton et al., 2005; Fiedler et al., 2003), more recent mutagenesis and crystallographic data have revealed the ligand-binding site as the second Ig domain (Barton et al., 2006).”
InfluentialSelf-citationReceptor Tyrosine Kinase-Mediated Angiogenesis
Jeltsch, M., Leppanen, V.-M., Saharinen, P., & Alitalo, K. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009183 · Cited by 175
“1) (Barton et al. 2006; Macdonald et al. 2006).”
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Anna Carota, I., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 135
Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Leppänen, V.-M., Saharinen, P., & Alitalo, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616166114 · Cited by 127
“Crystal structures of the angiopoietin/Tie2 ligand-binding domain (LBD) complexes demonstrate that Ang1 and Ang2 FLDs bind Tie2 in a similar manner (30, 33).”
BackgroundAngiopoietins and Tie2 in vascular inflammation
Parikh, S. M. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000361 · Cited by 132
Hansen, T. M., Singh, H., Tahir, T. A., & Brindle, N. P. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.007 · Cited by 126
The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation
Milam, K. E., & Parikh, S. M. (2014) · Tissue Barriers · doi:10.4161/21688362.2014.957508 · Cited by 116
“, also support the hypothesis that all Angpts interact with Tie2 in a structurally similar fashion.(61) More recently, these authors compared their original results to new crystallographic analysis of the Angpt-1-Tie2 complex.”
Angiopoietin-2 TIEs Up Macrophages in Tumor Angiogenesis
De Palma, M., & Naldini, L. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0171 · Cited by 101
“However, potential differences in themultimerization states of ANG1 and ANG2 are unlikely to account for their different effects on target cells, as both ANGs form similar high-order oligomers in solution (10).”
BackgroundDysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS
Parikh, S. M. (2013) · Virulence · doi:10.4161/viru.24906 · Cited by 112
Moss, A. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.009 · Cited by 113
“The P domain lies on the undersurface of the molecule and contains the Tie2 binding region [5].”
BackgroundVascular endothelial growth factors in cardiovascular medicine
Testa, U., Pannitteri, G., & Condorelli, G. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283117d37 · Cited by 95
The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation
Parikh, S. M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017010069 · Cited by 99
Vascular Disruption and the Role of Angiogenic Proteins After Spinal Cord Injury
Ng, M., Stammers, A. T., & Kwon, B. K. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0109-x · Cited by 94
“Ang1 and Ang2 bind to the same domain on Tie2 with similar affinities [15, 16, 132] and conformation [49].”
BackgroundMakinde, T., & Agrawal, D. K. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00254.x · Cited by 79
“Investigations have also suggested a third Ig-like domain, which folds together with the three EGFs into a compact, arrowhead-shaped structure [37, 38].”
BackgroundCorrelating structure and function during the evolution of fibrinogen‐related domains
Doolittle, R. F., McNamara, K., & Lin, K. (2012) · Protein Science · doi:10.1002/pro.2177 · Cited by 84
“Cell surface receptors and FReDs The crystal structure of the angiopoietin-2-receptor complex is an example of a FReP acting as a diffusible signal with a host cell receptor protein.(60) The ligand-receptor interaction itself is mostly spread across a large complementary hydrophobic surface.”
BackgroundArtificial Control of Cell Signaling and Growth by Magnetic Nanoparticles
Lee, J., Kim, E. S., Cho, M. H., Son, M., Yeon, S., Shin, J., & Cheon, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201001149 · Cited by 77
Wang, X. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.10.008 · Cited by 81
Structural basis for angiopoietin-1–mediated signaling initiation
Yu, X., Seegar, T. C. M., Dalton, A. C., Tzvetkova-Robev, D., Goldgur, Y., Rajashankar, K. R., Nikolov, D. B., & Barton, W. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216890110 · Cited by 69
“It remains unclear, however, exactly how the Ang ligands differentially effect the Tie1/ Tie2 interactions and Tie2 activation despite the available structural models of Ang2 and the Ang2/Tie2 complex (12, 13).”
BackgroundMethodInfluentialSelf-citationAngiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis
Brunckhorst, M. K., Wang, H., Lu, R., & Yu, Q. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4125 · Cited by 75
Koenig, P., Lee, C. V., Sanowar, S., Wu, P., Stinson, J., Harris, S. F., & Fuh, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662783 · Cited by 63
“567 Å over 1405 atoms (42)) and hVEGF in complex with the G6 Fab (root mean square deviation 0.”
BackgroundZuliani‐Alvarez, L., & Midwood, K. S. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0599 · Cited by 74
Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor
Daly, C., Qian, X., Castanaro, C., Pasnikowski, E. M., Jiang, X., Thomson, B. R., Quaggin, S. E., Papadopoulos, N. J., Wei, Y., Rudge, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18912-8 · Cited by 62
Identification and inhibition of drug target interference in immunogenicity assays
Zhong, Z. D., Dinnogen, S., Hokom, M. M., RAY, C. A., Weinreich, D. M., Swanson, S. J., & Chirmule, N. B. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.02.008 · Cited by 62
Mor-Cohen, R., Rosenberg, N., Landau, M., Lahav, J., & Seligsohn, U. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802399200 · Cited by 56
Nguyen, V. P. K. H., Chen, S. H., Trinh, J., Kim, H. L., Coomber, B. L., & Dumont, D. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-10 · Cited by 60
Galectins as modulators of receptor tyrosine kinases signaling in health and disease
Porębska, N., Poźniak, M., Matynia, A., Żukowska, D., Zakrzewska, M., Otlewski, J., & Opaliński, Ł. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.03.004 · Cited by 58
Regulation of Angiopoietin Signalling by Soluble Tie2 Ectodomain and Engineered Ligand Trap
Alawo, D. O. A., Tahir, T. A., Fischer, M., Bates, D. G., Amirova, S. R., & Brindle, N. P. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03981-6 · Cited by 50
Transmembrane domain‐mediated orientation of receptor monomers in active VEGFR‐2 dimers
Dell'Era-Dosch, D., & Ballmer‐Hofer, K. (2009) · The FASEB Journal · doi:10.1096/fj.09-132670 · Cited by 49
Computational Selection of RNA Aptamer against Angiopoietin-2 and Experimental Evaluation
Hu, W.-P., Kumar, J. V., Huang, C., & Chen, W. (2015) · BioMed Research International · doi:10.1155/2015/658712 · Cited by 52
“Then, we used a surface plasmon resonance (SPR) biosensor to test 3 mutant sequences of high ZRANK scores along with a high and a low affinity binding sequence as reported in the literature.”
Angiopoietin receptor TEK interacts with CYP1B1 in primary congenital glaucoma
Kabra, M., Zhang, W., Rathi, S., Mandal, A. K., Senthil, S., Pyatla, G., Ramappa, M., Banerjee, S., Shekhar, K., Marmamula, S., et al. (2017) · Human Genetics · doi:10.1007/s00439-017-1823-6 · Cited by 49
“1) (Barton et al. 2006).”
Ricciardi, C., Fiorilli, S., Bianco, S., Canavese, G., Castagna, R., Ferrante, I., Digregorio, G., Marasso, S. L., Napione, L., & Bussolino, F. (2009) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2009.10.006 · Cited by 48
“Interestingly, we have found a similar value, 2.0 ± 0.2, also for ligand/receptor ratio, although the Tie-2/Fc receptor is known to have just one binding site (Barton et al., 2006).”
BackgroundInfluentialManni, S., Mineev, K. S., Usmanova, D. R., Lyukmanova, E. N., Shulepko, M. A., Kirpichnikov, M. P., Winter, J., Matkovic, M., Deupí, X., Arseniev, A. S., et al. (2014) · Structure · doi:10.1016/j.str.2014.05.010 · Cited by 52
Molecular control of angiopoietin signalling
Singh, H., Tahir, T. A., Alawo, D. O. A., Issa, E., & Brindle, N. P. J. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110699 · Cited by 43
Macdonald, P. R., Progias, P., Ciani, B., Patel, S., Mayer, U., Steinmetz, M. O., & Kammerer, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605219200 · Cited by 59
Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
Whitehead, M., Osborne, A., Widdowson, P. S., Yu‐Wai‐Man, P., & Martin, K. R. G. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5140521 · Cited by 44
“The Ang fibrinogen-like domain has been shown to mediate the Tie2 agonistic properties of Ang1, and when this domain was transferred into Ang2, the protein developed constitutive Tie2 phosphorylating capabilities [27, 28].”
BackgroundA synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells
Mai, J., Song, S., Rui, M., Liu, D., Ding, Q., Peng, J., & Xu, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.024 · Cited by 44
Dalton, A. C., Shlamkovich, T., Papo, N., & Barton, W. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163732 · Cited by 45
Self-citationF-domain valency determines outcome of signaling through the angiopoietin pathway
Zhao, Y. T., Fallas, J. A., Saini, S., Ueda, G., Somasundaram, L., Zhou, Z., Raj, I. X., Ehnes, D. D., Xu, C., Carter, L. P., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153471 · Cited by 39
“The binding modes of the Ang1 and Ang2 F-domains to Tie2 are very similar (carbon alpha r.m.s.d. of 0.8 A; pdb id 4k0v (Yu et al , 2013) and 2gy7 (Barton et al , 2006)), and they have nearly identical tertiary structure (Yu et al , 2013) and similar Tie2-binding affinity (Maisonpierre et al ,…”
InfluentialWeeraratne, D. K., Lofgren, J. A., Dinnogen, S., Swanson, S. J., & Zhong, Z. D. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.07.010 · Cited by 37
“Multimerization in vivo is required to initiate binding to the Tie2 receptor and subsequent downstream signaling (Davis et al., 2003; Kim et al., 2005; Barton et al., 2006).”
BackgroundLee, H. S., Oh, S. J., Lee, K.-H., Lee, Y.-S., Ko, E., Kim, K. E., Kim, H.-C., Kim, S., Song, P. H., Kim, Y.-I., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572594 · Cited by 36
“Based on the crystal structure of the Ang-2 RBD (Protein Data Bank entry 2GY7) (15), we chose candidate residues as potential binding sites within the amino acid 352–366 region, generated several Ang-2 mutants, and tested their capacity to mediate the binding of Ang-2 to 5 1 integrin in an ELISA.”
BackgroundMethodInfluentialAngiopoietin‐Tie signaling in kidney diseases: an updated review
He, F.-F., Zhang, D., Chen, Q., Zhao, Y., Wu, L. L., Li, Z., Zhang, C., Jiang, Z., & Wang, Y. (2019) · FEBS Letters · doi:10.1002/1873-3468.13568 · Cited by 34
The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease
Bilimoria, J., & Singh, H. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1652650 · Cited by 39
“While Tie2 forms many interdomain interactions with Angpt2, the binding of this ligand does not cause any conformational changes in the kinase domain of the receptor [10].”
BackgroundTie2 and Eph Receptor Tyrosine Kinase Activation and Signaling
Barton, W. A., Dalton, A. C., Seegar, T. C. M., Himanen, J. P., & Nikolov, D. B. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009142 · Cited by 37
“However, a small shift in the overall ligand position is observed ( 1.5–6 Å), despite 4 Cite this article as Cold Spring Harb Perspect Biol 2014;6:a009142 the involvement and preservation of most equivalent contact residues between Ang1 and Ang2 (Barton et al. 2006; Yu et al. 2013).”
BackgroundSelf-citationSulfated glycans engage the Ang–Tie pathway to regulate vascular development
Griffin, M. E., Sorum, A. W., Miller, G. M., Goddard, W. A., & Hsieh‐Wilson, L. C. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-00657-7 · Cited by 37
Oh, N., Kim, K., Kim, S. J., Park, I., Lee, J. J., Seo, Y. S., An, H. J., Kim, H. M., & Koh, G. Y. (2015) · Scientific Reports · doi:10.1038/srep15291 · Cited by 34
Tropomyosin-receptor-kinases signaling in the nervous system.
Stoleru, B., Popescu, A. M., Tache, D. E., Neamţu, O. M., Emami, G., Tătăranu, L. G., Buteică, S. A., Dricu, A., & Purcaru, Ş. O. (2013) · Europe PMC (PubMed Central) · Cited by 43
Dimerization of Tie2 mediated by its membrane-proximal FNIII domains
Moore, J. O., Lemmon, M. A., & Ferguson, K. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617800114 · Cited by 30
“Both bury more than 1,000 Å(2) of surface area in the dimer interface, comparable to the 1,300 Å(2) buried when Ang1 binds to Tie2 (20).”
BackgroundKim, H.-Z., Jung, K., Kim, H. M., Cheng, Y., & Koh, G. Y. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.018 · Cited by 39
Zhu, H., Lu, Y., Xia, J., Liu, Y., Chen, J., Lee, J., Koh, K., & Chen, H. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04448 · Cited by 29
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Kiss, E. A., & Saharinen, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_4 · Cited by 32
Jo, G., Bae, J., Hong, H. J., Han, A. R., Kim, D.-K., Hong, S. P., Kim, J. A., Lee, S., Koh, G. Y., & Kim, H. M. (2021) · Nature Communications · doi:10.1038/s41467-021-26620-1 · Cited by 32
Sinha, A., Kawakami, J., Cole, K. S., Ladutska, A., Nguyen, M. Y., Zalmai, M. S., Holder, B. L., Broerman, V. M., Matthews, R. T., & Bouyain, S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104952 · Cited by 26
“In fact, this site is also used by the C-terminal Fg domain in fibrinogen to interact with the α chain of fibrin or by the Fg module of angiopoietin-2 to interact with the receptor tyrosine kinase Tie2 (35, 36).”
BackgroundHa, J., Tu, H.-C., Wilkens, S., & Loh, S. N. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100446 · Cited by 22
Reiss, Y. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_2 · Cited by 25
Role of Angiopoietin/Tie2 System in Sepsis: A Potential Therapeutic Target
Chi, Y., Yu, S., Jia, Y., Liu, D., Zhuo, M., & Li, X. (2024) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296241238010 · Cited by 30
“16 They are members of Tie family, serving as receptors of Ang to promote angiogenesis as well as maintain vascular homeostasis.”
BackgroundInfluentialStevens, M. E., Dhillon, J., Miller, C., Solek, C. M., Majeske, A. J., Zuelke, D. R., Rast, J. P., & Smith, L. C. (2010) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2010.03.010 · Cited by 20
“2), which, in mammalian Tie proteins, are involved with ligand binding based on crystal structure (Barton et al., 2006).”
BackgroundIn search of biomarkers for diagnosing and managing neonatal sepsis: the role of angiopoietins
Mussap, M., Cibecchini, F., Noto, A., & Fanos, V. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.830411 · Cited by 19
“Angiopoietins bind the second immunoglobulin motif of Tie-2 whereby they activate Tie-2 and, indirectly, Tie-1 in Tie-1/Tie-2 heterodimers [6].”
BackgroundQiao, Y., Chen, Y., Tan, C., Sun, X., Chen, X., & Chen, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.764509 · Cited by 22
“For variants located within immunoglobulin (Ig)-like domains and the epidermal growth factor (EGF)-like domain, the Tie2 ligandbinding domain crystal structure (PDB ID: 2GY5, 23-445 aa) was utilized as the template (Barton et al., 2006).”
MethodPalma, L. M. A., Flamme, H., Gerke, I., & Kreuzer, K. (2016) · Cancer Microenvironment · doi:10.1007/s12307-016-0180-7 · Cited by 17
Update Overview of the Role of Angiopoietins in Lung Cancer
Tsakogiannis, D., Nikolakopoulou, A., Zagouri, F., Stratakos, G., Syrigos, K., Zografos, E., Koulouris, N. G., & Bletsa, G. (2021) · Medicina · doi:10.3390/medicina57111191 · Cited by 21
Brindle, N. P. J., Sale, J. E., Arakawa, H., Buerstedde, J.-M., Nuamchit, T., Sharma, S., & Steele, K. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510578 · Cited by 18
“The positions of the amino acid changes in the evolved ectodomain are indicated on the structure of Tie2 in complex with Ang2 (PDB accession number 2GY7 (26)).”
BackgroundInfluentialExploring Angiopoietin-2: Clinical Insights and Experimental Perspectives in Kidney Diseases
Luo, A.-J., Chang, F., & Lin, S. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.001 · Cited by 20
Ruan, Y., Dong, W., Kang, L., Lei, X., Zhang, R., Wang, F., & Zhu, X. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00190 · Cited by 17
“Besides, because Ang1 and Ang2 bind to Tie2 in a similar way (45, 46), the binding of Ang2 to Tie2 might lead to the inhibition of the signal transduction of Tie2 induced by Ang1 when the ratio of Ang2/Ang1 increased and make Ang2 play an antagonistic role of Tie2, thus making vascular instability.”
BackgroundThe receptor tyrosine kinase Tie1 is expressed and activated in epithelial tumour cell lines
Rees, K. A., Singh, H., & Brindle, N. P. J. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.4.893 · Cited by 15
Saharinen, P., Jeltsch, M., Santoyo, M. M., Leppänen, V., & Alitalo, K. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_16 · Cited by 21
“The structure of the TIE2 ligand binding domain revealed N-glycosylation in four of these sites, in Asn140 and Asn158 in Ig2 as well as in Asn399 and Asn438 in Ig3 [ 103 ] .”
BackgroundInfluentialTumor Angiogenesis: A Key Target for Cancer Therapy
(2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2 · Cited by 15
Spiegelaere, W. D., Cornillie, P., Broeck, W. V. D., Plendl, J., & Bahramsoltani, M. (2011) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2011-1393 · Cited by 14
“The downregulation of TIE1 after 40 days in culture changes the TIE2/TIE1 ratio in favor of TIE2, enabling its stabilizing effect.”
Structure of the EphB6 receptor ectodomain
Mason, E. O., Goldgur, Y., Tzvetkova‐Robev, D., Freywald, A., Nikolov, D. B., & Himanen, J. P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247335 · Cited by 14
“These fragments were cloned into a lab made version of the pcDNA 3.1 hygromycin vector encoding also the Fc portion of the human IgG [53] to generate EphB6-ECD-Fc fusions.”
BackgroundInfluentialSelf-citationThe Angiopoietin—Tie System: Common Signaling Pathways for Angiogenesis, Cancer, and Inflammation
Reiss, Y., Scholz, A., & Plate, K. H. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2907-8_13 · Cited by 18
“However, more recent evidence suggests the second Ig domain as the primary angiopoietin binding site [42].”
BackgroundInfluentialAngiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors
Pereira, S. S., Oliveira, S. B., Monteiro, M. P., & Pignatelli, D. (2021) · Cancers · doi:10.3390/cancers13051030 · Cited by 16
“Different studies reported that it is unlikely that Tie2 can act differently when binding to Ang1 and Ang2, since both angiopoietins interact with Tie2 in a structurally similar manner and pointed out that other still unidentified mechanisms were likely to be involved [26].”
BackgroundRobust de novo design of protein binding proteins from target structural information alonePreprint
Cao, L., Coventry, B., Goreshnik, I., Huang, B., Park, J. S., Jude, K. M., Marković, I., Kadam, R. U., Verschueren, K. H. G., Verstraete, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.04.459002 · Cited by 12
Bate, N., Lodge, J., & Brindle, N. P. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100888 · Cited by 10
“F, the structure of Tie2 ectodomain in complex with Ang1 (PDB accession number 4K0V (16)) and Ang2 (PDB accession number 2GY7 (15)) is shown highlighting the residues interacting with Ser164.”
BackgroundInfluentialConnection of Pericyte–Angiopoietin-Tie-2 System In Diabetic Retinopathy: Friend Or Foe?
Cai, J., Ruan, Q., Chen, Z. J., & Han, S. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.170 · Cited by 10
Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis
Suzuki, T., Loyde, E., Chen, S., Etzrodt, V., Idowu, T. O., Clark, A. J., Saadé, M. C., Flores, B. M., Lu, S., Birrane, G., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci174135 · Cited by 15
“The FL domain is required for binding of ANGPT2 to the Tie2 receptor (17, 30).”
Artificial Control of Cell Signaling and Growth by Magnetic Nanoparticles
Lee, J., Kim, E., Cho, M. H., Son, M., Yeon, S., Shin, J., & Cheon, J. (2010) · Angewandte Chemie · doi:10.1002/ange.201001149 · Cited by 8
Song, Y., Dilger, E. K., Bell, J. K., Barton, W. A., & Fang, X. (2010) · BMB Reports · doi:10.3858/bmbrep.2010.43.8.541 · Cited by 7
Self-citationVEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells
Deissler, H. L., Rehák, M., & Lytvynchuk, L. M. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110062 · Cited by 7
Structural Features of the Receptor Tyrosine Kinase Ectodomains
Lawrence, M. C., & Ward, C. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2053-2_8 · Cited by 6
“through the formation of ligand-induced clusters [ 34 ].”
BackgroundInfluentialAssessing the Quality of in Silico Produced Biomolecules: The Discovery of a New Conformer
Cataldo, R., Giotta, L., Guascito, M. R., & Alfinito, E. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b11456 · Cited by 7
Ocran, E., Chornenki, N. L. J., Bowman, M. L., Sholzberg, M., & James, P. D. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2221846 · Cited by 6
“Increased VEGFR-2 dependent angiogenesis has also been described in VWF-deficient ECs [59].”
BackgroundRole of von Willebrand factor in the angiogenesis of lung adenocarcinoma (Review)
Li, X., & Lü, Z. (2022) · Oncology Letters · doi:10.3892/ol.2022.13319 · Cited by 9
“Barton et al found an increase in Ang‐2 in VWF‐deficient ECs in vitro (57).”
BackgroundShlamkovich, T., Aharon, L., Barton, W. A., & Papo, N. (2017) · Oncotarget · doi:10.18632/oncotarget.16827 · Cited by 6
“The most commonly observed mutations fall into two classes: those located within the Ang2-BD/Tie2 binding interface (residues 421, 432, 434, 436, 467, 469, 470 and 475), and those located along the Ang2BD backbone (residues 302, 304, 324, 330, 343, 353, 359, 386, 389, 393, 402, 407, 413 and 415).”
BackgroundResultInfluentialSelf-citationResidue‐level determinants of angiopoietin‐2 interactions with its receptor Tie2
Bakhman, A. F., Rabinovich, E., Shlamkovich, T., Papo, N., & Kosloff, M. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25638 · Cited by 6
“Mickey Kosloff acknowledges support by grants from the Israel Science Foundation (grant numbers 1454/13, 1959/13, 2155/15) and from the Israel Ministry of Science, Technology and Space, Israel, and the Italian Ministry of Foreign Affairs (3-10704).”
BackgroundAnti-angiogenic Targets: Angiopoietin and Angiopoietin-Receptors
Kiss, E. A., & Saharinen, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-31215-6_4-1 · Cited by 11
“These domains fold as a compact, arrowhead-shaped structure that binds the ANGPT1 and ANGPT2 FLDs, utilizing a lockand-key mode of ligand recognition that is unique for RTKs (Barton et al. 2006; Macdonald et al. 2006).”
BackgroundInfluentialMonast, C. S., Mehta, N., & Lazzara, M. J. (2013) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-013-0303-x · Cited by 4
Koya, Y., Nara, H., Yagi, S., Ueno, C., & Kamohara, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-93660-4 · Cited by 4
Discovery of loperamide as an antagonist of angiopoietin1 and angiopoietin2 by virtual screening
Gong, X. W., Mai, J., & Xu, Y. H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.036 · Cited by 3
Angiopoietins and Tie Receptors
Saharinen, P., Eklund, L., & Alitalo, K. K. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_10 · Cited by 4
“1B) [51].”
BackgroundInfluential
Metadata
- Authors
- Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Nikolov, Dimitar B
- Venue
- Nature Structural & Molecular Biology
- Published
- 2006-05-28
- Volume
- 13
- Issue
- 6
- Pages
- 524-532
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2100589229
- Cited by
- 134
- References
- 51
- Citations by year
- 2026: 9 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 11 · 2020: 4 · 2019: 8 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 12 · 2012: 7
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL077249)
- National Center for Research Resources (RR 15301, P41RR015301)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Tie2 receptor, angiopoietin-2, receptor tyrosine kinase, ligand-binding domain, immunoglobulin domains, epidermal growth factor domain, receptor activation mechanism, angiogenesis, structure-guided mutagenesis
- MeSH terms
- Amino Acid Sequence, Calcium, Chromatography, Gel, Epidermal Growth Factor, Fibrinogen, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Sequence Homology, Amino Acid, Crystallography, X-Ray, Angiopoietin-2, Receptor, TIE-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.